Clinique du Souffle la Vallonie
Lodève, 34700, France
NCT Number: NCT05852821
The purpose of this clinical study is to determine if a learning effect exists when the 5STS is assessed remotely via videoconference in patients with COPD.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lodève, 34700, France
Pulmonary rehabilitation (PR) is an essential therapy for improving exercise tolerance and quality of life in patients with chronic respiratory disease. It is now available remotely thanks to advances in information and communication technologies. Pulmonary telerehabilitation facilitates care access for patients living far from specialized centers. It requires, for a complete and coherent transposition, to be able to evaluate the patients remotely in order to measure the evolution of their functional capacities and to ensure their follow-up. Among the tests already implemented at home and remotely via video-conference, the 5-repetition sit-to-stand test (5STS) is the most suitable. This test requires only a short time to perform, little space and no specific equipment. However, two major limits remain to be checked before being able to consider its remote and routine implementation. First of all, it is important to study its feasibility. Moreover, like other functional tests, it raises the question of a possible learning effect (LE). In the perspective of a current use of the 5STS remotely, it is therefore also essential to assess the existence of a potential LE which would condition the methods of administering the test and its interpretation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be asked to perform several times the 5STS test, from their home through videoconference, on 3 occasions (day 1, 24h later and 1month later).
Time frame: 1 day
Time frame: 1 day
Time frame: 2 days
Time frame: 1 month
Time frame: 1 month
Reproducibility is objectified by the test-retest reliability between two trials of the same series (first and fifth trials of V1) and between two series (V1-V2; V2-V3; V1 -V3).
Time frame: through study completion, an average of 1 year
Time frame: 1 month
Satisfaction will be assessed with a questionnaire at the end of visit 3.
Time frame: through study completion, an average of 1 year
Time frame: through study completion, an average of 1 year
Korian
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT04911764
Behavior, COPD
Limoges, France
View Trial DetailsNCT04711057
Behavior, Chronic Disease
Aveiro, Portugal
View Trial DetailsNCT05319236
Cardiac Disease, Cardiovascular Abnormalities
Washington D.C., District of Columbia, United States
View Trial Details